Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ricordi, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ricordi, C.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 52:1595-1603, 2003
© 2003 by the American Diabetes Association, Inc.


Perspectives in Diabetes

Lilly Lecture 2002

Islet Transplantation: A Brave New World

Camillo Ricordi

From the Diabetes Research Institute and the Departments of Surgery, Medicine, Pathology, Microbiology, and Immunology, University of Miami School of Medicine, Miami, Florida

The first 300 words of the full text of this article appear below.

It has indeed been a distinct honor to be the recipient of the 2002 Outstanding Scientific Achievement Award, and I was happy to accept it, on behalf of the entire islet transplant field, as there have been many surgeons, physicians, and scientists who have worked as a team, moving this field forward. I was born the year the Lilly Lecture was established, 1957, and since then, this is the first time that the award goes to islet transplantation, representing indeed a very important recognition to all of us in the field. Therefore, I’d like to outline the major steps in the development of islet transplantation, from a hypothesis, to its clinical application, through what we call translational research, bench to bedside. At the end, some of the challenges ahead, including novel immunomodulatory strategies, tolerance induction, and the development of alternative sources of insulin-producing tissue, are discussed.

The challenge, as you may predict, is diabetes. A syndrome well known since over 3,500 years ago, even if the term "diabetes" was coined in the first century by Arataeus from the Greek "siphon" or "pipe-like." Arataeus described diabetes as "a melting down of flesh and limbs into urine." It took over 3,500 years to link diabetes to the pancreas, and until insulin was discovered, diabetes remained a devastating, deadly disease, often treated by starvation. The discovery of insulin, by Banting and Best in 1922, changed the course of history in the treatment of the disease, and suddenly children with diabetes could be offered a new chance at life. While definitely a life-saving breakthrough, insulin treatment still cannot fully prevent chronic complications, and intensive insulin treatment to improve metabolic control has paralleled an increased risk of severe hypoglycemia (1). The hypothesis that replacement of the endocrine pancreas by transplantation of insulin-producing tissue . . . [Full Text of this Article]

Address correspondence and reprint requests to Camillo Ricordi, Department of Surgery, Diabetes Research Institute, 1450 NW 10th Ave., Miami, FL 33136. E-mail: ricordi@miami.edu


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Ann. N. Y. Acad. Sci.Home page
A. PILEGGI, L. COBIANCHI, L. INVERARDI, and C. RICORDI
Overcoming the Challenges Now Limiting Islet Transplantation: A Sequential, Integrated Approach
Ann. N.Y. Acad. Sci., October 1, 2006; 1079(1): 383 - 398.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
K. M. Gillespie
Type 1 diabetes: pathogenesis and prevention.
Can. Med. Assoc. J., July 18, 2006; 175(2): 165 - 170.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Battaglia, A. Stabilini, E. Draghici, S. Gregori, C. Mocchetti, E. Bonifacio, and M.-G. Roncarolo
Rapamycin and Interleukin-10 Treatment Induces T Regulatory Type 1 Cells That Mediate Antigen-Specific Transplantation Tolerance
Diabetes, January 1, 2006; 55(1): 40 - 49.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
M. Brissova, M. J. Fowler, W. E. Nicholson, A. Chu, B. Hirshberg, D. M. Harlan, and A. C. Powers
Assessment of Human Pancreatic Islet Architecture and Composition by Laser Scanning Confocal Microscopy
J. Histochem. Cytochem., September 1, 2005; 53(9): 1087 - 1097.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Liang, T. Huang, C. Zhang, I. Todorov, M. Atkinson, F. Kandeel, S. Forman, and D. Zeng
Donor CD8+ T cells facilitate induction of chimerism and tolerance without GVHD in autoimmune NOD mice conditioned with anti-CD3 mAb
Blood, March 1, 2005; 105(5): 2180 - 2188.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2003 by the American Diabetes Association.